Pediatric Acute Promyelocytic Leukemia: A Rare Case Report
DOI:
https://doi.org/10.21276/apalm.3254Keywords:
Disseminated intravascular coagulation, all-trans retinoic acid, hypergranular, microgranular, paediatric APMLAbstract
Acute Promyelocytic leukemia (APML) belongs to French American British (FAB) classification M3 subtype of acute myeloid leukemia & is characterized by t(15;17) and resultant PML-RARA fusion gene. APML accounts for 5-10 % in pediatric age group. Patients usually present with bleeding manifestations, weakness and increased propensity for disseminated intravascular coagulation. Extramedullary involvement is rare. It is a hematologic disease presenting as medical emergency and can be diagnosed with certainty by morphological examination of peripheral blood film & bone marrow aspirate to allow initiation of targeted therapy in order to reduce mortality. Patients with APML receive combination of all-trans retinoic acid (ATRA) & arsenic trioxide to induce terminal differentiation of blasts. We present a case of APML in a four years old child presented in the department of clinical hematology with pallor, lymphadenopathy and hepatosplenomegaly.
References
Singh T. Atlas & Text of Hematology. 4th ed. Sirmour(HP): Avichal; 2018.
De TH, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor gene to a novel transcribed locus. Nature. 1990;347:558-561.
Conneely SE, Stevens AM. Advances in Pediatric Acute Promyelocytic Leukemia. Mdpijournalchildren. 2020;7-11.
Chen Y, Hagop K, Ravandi F. Acute Promyelocytic Leukemia: A population based study on incidence and survival in the US, 1975-2008. Cancer. 2012;118(23):5811-18.
Andrade FG, Feliciano SVM, Cezar SI, Brisson GD, Bueno FV, Vianna DT, et al. Pediatric Acute Promyelocytic Leukemia: Epidemiology, Molecular features and Importance of GST-theta 1 in chemotherapy response and outcome. Front Oncol. 2021;11.
Rajpurkar M, Alonzo TA, Wang YC, Gerbing RB, Gamis AS, Feusner JH, et al. Risk markers for significant bleeding and thrombosis in pediatric acute promyelocytic leukemia: Report from the children’s oncology group study AAML0631. J Pediatr Hematol Oncol. 2019;41:51-55.
Taga T, Tomizawa D, Takahashi H, Adachi S. Acute myeloid leukemia in children: current status and future directions. Pediatr Int. 2016;58:71-80.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Renuka Verma, Aakanksha Rawat, Rajnish Kalra, Monika Gupta, Anjali Ahlawat, Pooja Rathee
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
How to Cite
